三友醫療(688085.SH):擬參與認購法國Implanet公司公開發行股份
格隆匯12月8日丨三友醫療(688085.SH)公佈,公司擬使用自有資金500萬歐元,通過全資子公司三友(香港)國際醫療控股有限公司認購Implanet公司的公開發行股份。本次投資前公司持有Implanet公司41.03%的股權,本次投資完成後,公司對Implanet公司的持股比例約增加至78.48%-85.42%,Implanet公司將成為公司的控股孫公司,Implanet公司將納入公司合併報表範圍之內。
公司本次對外投資完成後,公司將在國際高端骨科市場擁有一個具有獨立研發能力和完備質量體系及公司建制的實體公司,可以利用Implanet公司現有營銷網絡,向國際高端骨科市場輸出自主研發的療法創新技術和產品;同時將Implanet公司先進的脊柱創新療法JAZZ拉力帶系列產品引進國內,進一步豐富公司產品線;Implanet公司目前仍處於虧損狀態,預計完成收購後將對公司2024年的業績產生不利影響,同時公司預計將新增商譽約2500萬元—4500萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.